Hims & Hers Health, Inc. (HIMS) stock
HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30187% above fair value
$18.56−1.17 (-5.93%)
Close on Nov 16, 2026Market cap $4.33BP/E –Yield –
Hims & Hers Health cash
Cash and short-term investments held at the end of each period.
Hims & Hers Health's cash was $841.05M at Jun 30, 2026. For fiscal 2025 it was $577.49M, up 91.8% from the year before. The highest annual figure on record is $577.49M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $577.49M | +91.8% |
| FY2024 | Dec 31, 2024 | $301.11M | +36.3% |
| FY2023 | Dec 31, 2023 | $220.98M | +22.4% |
| FY2022 | Dec 31, 2022 | $180.48M | -27.3% |
| FY2021 | Dec 31, 2021 | $248.13M | +145.2% |
| FY2020 | Dec 31, 2020 | $101.21M | +344.0% |
| FY2019 | Dec 31, 2019 | $22.80M | -45.3% |
| FY2018 | Dec 31, 2018 | $41.65M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $841.05M | -26.5% |
| Q1 FY2026 | Mar 31, 2026 | $750.88M | +132.7% |
| Q4 FY2025 | Dec 31, 2025 | $577.49M | +91.8% |
| Q3 FY2025 | Sep 30, 2025 | $629.74M | +147.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.14B | +403.6% |
| Q1 FY2025 | Mar 31, 2025 | $322.67M | +58.5% |
| Q4 FY2024 | Dec 31, 2024 | $301.11M | +36.3% |
| Q3 FY2024 | Sep 30, 2024 | $254.07M | +19.6% |
| Q2 FY2024 | Jun 30, 2024 | $227.29M | +17.7% |
| Q1 FY2024 | Mar 31, 2024 | $203.59M | +10.4% |
| Q4 FY2023 | Dec 31, 2023 | $220.98M | +22.4% |
| Q3 FY2023 | Sep 30, 2023 | $212.50M | +7.1% |
| Q2 FY2023 | Jun 30, 2023 | $193.14M | -0.9% |
| Q1 FY2023 | Mar 31, 2023 | $184.39M | -9.2% |
| Q4 FY2022 | Dec 31, 2022 | $180.48M | -27.3% |
| Q3 FY2022 | Sep 30, 2022 | $198.39M | -21.4% |
| Q2 FY2022 | Jun 30, 2022 | $194.98M | -38.6% |
| Q1 FY2022 | Mar 31, 2022 | $203.05M | -37.2% |
| Q4 FY2021 | Dec 31, 2021 | $248.13M | +145.2% |
| Q3 FY2021 | Sep 30, 2021 | $252.43M | +574.8% |
| Q2 FY2021 | Jun 30, 2021 | $317.32M | +580.2% |
| Q1 FY2021 | Mar 31, 2021 | $323.27M | +486.0% |
| Q4 FY2020 | Dec 31, 2020 | $101.21M | +344.0% |
| Q3 FY2020 | Sep 30, 2020 | $37.41M | +1999.7% |
| Q2 FY2020 | Jun 30, 2020 | $46.65M | – |
| Q1 FY2020 | Mar 31, 2020 | $55.17M | – |
| Q4 FY2019 | Dec 31, 2019 | $22.80M | -45.3% |
| Q3 FY2019 | Sep 30, 2019 | $1.78M | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Apr 9, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $41.65M | – |
See a number that looks wrong?